Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

Author(s): S. Crispi, I. Cardillo, E. P. Spugnini, G. Citro, S. Menegozzo, A. Baldi.

Abstract:

Malignant mesothelioma (MM) is a rare, highly aggressive tumor that arises from the surface serosal cells (pleural, peritoneal and pericardial cavities). Epidemiological and clinical data show that there is an association between asbestos exposure and MM development, even if the exact mechanism whereby asbestos induces MM is unknown. The continuing identification and elucidation of the molecular defects involved in mesothelioma pathogenesis and progression should lead to better disease control and greater therapeutic options in the near future. Goal of this article is to summarize the most recent advances in molecular pathogenesis of mesothelioma with particular emphasis on genes that could be considered as biomarkers or therapeutic targets and discuss possible clinical implications of these findings.

Keywords: Mesothelioma, pathogenesis, biomarkers, cDNA array

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

VOLUME: 10
ISSUE: 1
Year: 2010
Page: [19 - 26]
Pages: 8
DOI: 10.2174/156800910790980232